Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant in insomnia disorder
NCT07028697Phase 3Completed
- Sponsor
- Nxera Pharma
- Start
- Dec 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daridorexant in insomnia disorder, sponsored by Nxera Pharma. Started Dec 2024; status: completed.
02
Drugs
daridorexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT07028697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07028697.